期刊文献+

恩度结合化疗治疗晚期非小细胞肺癌疗效及安全性分析

Efficacy and safety of Endostar combined with chemotherapy in treatment of advanced non-small cell lung cancer
下载PDF
导出
摘要 目的:探析恩度结合化疗治疗晚期非小细胞肺癌的疗效及安全性。方法:收治晚期非小细胞肺癌患者100例,随机分为研究组和参照组,各50例;参照组采用单一化疗,研究组给予恩度结合化疗治疗。结果:研究组治疗有效率优于参照组(P<0.05)。结论:晚期非小细胞肺癌患者行恩度结合化疗治疗,可以有效改善患者的生存质量,提升治疗有效率,并且无显著不良反应。 Objective:To explore the efficacy and safety of Endostar combined with chemotherapy in the treatment of advanced non-small cell lung cancer.Methods:100 patients with advanced non-small cell lung cancer were randomly divided into the study group and the control group with 50 cases in each group.Results:The effective rate of the study group was better than that of the reference group(P 〈 0.05).Conclusion:Enthusiasm combined with chemotherapy can effectively improve the life quality of patients with advanced non-small cell lung cancer,improve the efficiency of treatment,and no significant adverse reactions.
作者 杨相辉 Yang Xianghui(Department of Ontology,the Central Hospital of Changsha City,Hunan 410004)
出处 《中国社区医师》 2018年第33期56-57,共2页 Chinese Community Doctors
关键词 晚期非小细胞肺癌 恩度 化疗 效果 安全性 Advanced non-small cell lung cancer Grace Chemotherapy Effect Safety
  • 相关文献

参考文献5

二级参考文献34

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部